Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down1.35% Nasdaq Down1.12%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT

2.19 Down 0.01(0.45%) Jun 19, 4:01PM EDT

Add to Portfolio
Key StatisticsGet Key Statistics for:
Data provided by Capital IQ, except where noted.
Valuation Measures 
Market Cap (intraday)5:115.47M
Enterprise Value (Jun 20, 2013)3:91.37M
Trailing P/E (ttm, intraday):N/A
Forward P/E (fye Dec 31, 2014)1:N/A
PEG Ratio (5 yr expected)1:N/A
Price/Sales (ttm):N/A
Price/Book (mrq):6.16
Enterprise Value/Revenue (ttm)3:NaN
Enterprise Value/EBITDA (ttm)6:-8.25
Financial Highlights 
Fiscal Year
Fiscal Year Ends:Dec 30
Most Recent Quarter (mrq):Mar 31, 2013
Profitability
Profit Margin (ttm):N/A
Operating Margin (ttm):N/A
Management Effectiveness
Return on Assets (ttm):-35.22%
Return on Equity (ttm):-92.72%
Income Statement
Revenue (ttm):N/A
Revenue Per Share (ttm):N/A
Qtrly Revenue Growth (yoy):N/A
Gross Profit (ttm):N/A
EBITDA (ttm)6:-11.08M
Net Income Avl to Common (ttm):-11.58M
Diluted EPS (ttm):-0.26
Qtrly Earnings Growth (yoy):N/A
Balance Sheet
Total Cash (mrq):24.10M
Total Cash Per Share (mrq):0.46
Total Debt (mrq):0.00
Total Debt/Equity (mrq):N/A
Current Ratio (mrq):21.52
Book Value Per Share (mrq):0.36
Cash Flow Statement
Operating Cash Flow (ttm):-11.01M
Levered Free Cash Flow (ttm):-6.86M
View Financials
Income Statement - Balance Sheet - Cash Flow
Trading Information 
Stock Price History
Beta:0.92
52-Week Change3:-40.16%
S&P500 52-Week Change3:22.89%
52-Week High (Jul 3, 2012)3:3.96
52-Week Low (Nov 14, 2012)3:1.51
50-Day Moving Average3:2.45
200-Day Moving Average3:2.36
Share Statistics
Avg Vol (3 month)3:479,300
Avg Vol (10 day)3:776,600
Shares Outstanding5:52.73M
Float:52.68M
% Held by Insiders1:5.96%
% Held by Institutions1:13.10%
Shares Short (as of May 31, 2013)3:3.54M
Short Ratio (as of May 31, 2013)3:8.80
Short % of Float (as of May 31, 2013)3:6.90%
Shares Short (prior month)3:4.01M
Dividends & Splits
Forward Annual Dividend Rate4:N/A
Forward Annual Dividend Yield4:N/A
Trailing Annual Dividend Yield3:N/A
Trailing Annual Dividend Yield3:N/A
5 Year Average Dividend Yield4:N/A
Payout Ratio4:N/A
Dividend Date3:N/A
Ex-Dividend Date4:N/A
Last Split Factor (new per old)2:N/A
Last Split Date3:N/A

See Key Statistics Help for definitions of terms used.
Abbreviation Guide: K = Thousands; M = Millions; B = Billions
mrq = Most Recent Quarter (as of Mar 31, 2013)
ttm = Trailing Twelve Months (as of Mar 31, 2013)
yoy = Year Over Year (as of Mar 31, 2013)
lfy = Last Fiscal Year (as of Dec 31, 2012)
fye = Fiscal Year Ending
1 Data provided by Thomson Reuters
2 Data provided by EDGAR Online
3 Data derived from multiple sources or calculated by Yahoo! Finance
4 Data provided by Morningstar, Inc.
5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
6 EBITDA is calculated by Capital IQ using methodology that may differ from that used by a company in its reporting

Currency in USD.